VFA
LUMO

Virtus Fund Advisers’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Virtus Fund Advisers’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$336K Buy
+4,608
New +$381K ﹤0.01% 429
2014
Q3 		– Sell
-188
Closed -$45K – 2010
2014
Q2 		$45K Buy
+188
New +$38.2K ﹤0.01% 1946

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virtus Fund Advisers's LUMO Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2017: 4,608 shares worth $336K. The stake represents ﹤0.01% of the portfolio and ranks #429 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in LUMO as recently as Q2 2014.

Virtus Fund Advisers first reported a position in LUMO in Q2 2014 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold LUMO as of Q4 2017.

  • Virtus Fund Advisers held 4,608 shares of Lumos Pharma, Inc. Common Stock worth $336K as of Q4 2017.
  • Lumos Pharma, Inc. Common Stock was a new Virtus Fund Advisers position in Q4 2017.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #429 holding.
  • Virtus Fund Advisers first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2014 and has held it in 2 quarters since.
  • 130 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.